The federal response to the coronavirus pandemic has put a Richmond, VA, start-up called Phlow Corp. in the role of preventing shortages of essential medicines and shielding the US market from global competition, particularly from China.
The decision the Health and Human Services Department announced 19 May to provide Phlow with $354m of COVID-19 response funding...





